Portnoy Adam D.'s Form 4 filing
Diversified Healthcare Trust (DHC) · filed Jun 6, 2023
- Accession no.
- 0001104659-23-068597
- Filed
- Jun 6, 2023
- Trade date
- Jun 2-6, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $9.80M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Portnoy Adam D.CIK 0001273871 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 | Common Shares of Beneficial Interest | AGrant or awardAcquired | +20,000 | –F1 | – | 214,373.55 | Direct | |
| Jun 2, 2023 | Common Shares of Beneficial Interest | PPurchaseAcquired | +1,625,481 | $1.69F2 | +$2,747,062.89 | 7,330,141 | Indirect | |
| Jun 5, 2023 | Common Shares of Beneficial Interest | PPurchaseAcquired | +2,318,081 | $1.75F3 | +$4,056,641.75 | 9,648,222 | Indirect | |
| Jun 6, 2023 | Common Shares of Beneficial Interest | PPurchaseAcquired | +1,603,082 | $1.87F4 | +$2,997,763.34 | 11,251,304 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Transaction reported is grant of shares pursuant to the equity compensation plan of Diversified Healthcare Trust (the "Issuer").
Referenced by the price of 1 transaction in Table I.
- F2
The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.665 to $1.71 per share. Mr. Portnoy, as the sole trustee, an officer and the controlling shareholder of ABP Trust, undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F3
The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.67 to $1.79 per share. Mr. Portnoy, as the sole trustee, an officer and the controlling shareholder of ABP Trust, undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.685 to $1.98 per share. Mr. Portnoy, as the sole trustee, an officer and the controlling shareholder of ABP Trust, undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.